A case of acquired angioedema.

Abstract

ABSTRACT:

Acquired angioedema is a rare disorder characterized by nonurticarial angioedema secondary to deficiency or altered activity of C1-esterase inhibitor protein. This article describes a patient whose recurrent angioedema was initially diagnosed as angiotensin-converting enzyme (ACE) inhibitor-induced angioedema. However, after further testing, she was diagnosed with acquired angioedema and subsequently treated with a synthetic bradykinin B2-receptor antagonist.

• Authors: Arielle D Zwanziger
• Journal: JAAPA : official journal of the American Academy of Physician Assistants (JAAPA) Vol. 35 Issue 5 Pg. 36-38 (May 01 2022) ISSN: 1547-1896 [Print] United States
• PMID: 35472033 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright © 2022 American Academy of Physician Associates.

Chemical References

• Angiotensin-Converting Enzyme Inhibitors
• Bradykinin

Topics

• Angioedema (chemically induced, diagnosis)
• Angiotensin-Converting Enzyme Inhibitors (adverse effects)
• Bradykinin (adverse effects)
• Female
• Humans